08:51 AM EDT, 06/24/2024 (MT Newswires) -- US equity futures were mixed before Monday's opening bell as traders looked ahead to a key inflation metric due for release later in the week.

Dow Jones Industrial Average futures increased 0.2%, S&P 500 futures was marginally declining, while Nasdaq futures slipped 0.2%.

The Personal Income and Outlays Report, which includes the personal consumption expenditure core price index, for May is due Friday.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 0.2% at $84.50 per barrel and US West Texas Intermediate crude up nearly 0.1% at $80.78 per barrel.

The Dallas Fed General Activity Index is slated for release at 10:30 am ET.

In other world markets, Japan's Nikkei closed 0.5% higher, Hong Kong's Hang Seng ended flat, and China's Shanghai Composite finished 1.2% lower. Meanwhile, UK's FTSE 100 gained 0.4%, and Germany's DAX index increased 0.6% in Europe's early afternoon session.

In equities, shares of Alimera Sciences ( ALIM ) shares were 77% higher pre-bell after the company agreed to be acquired by ANI Pharmaceuticals ( ANIP ) . Regulus Therapeutics (RGLS) shares rose 11% after the company reported that its treatment candidate for autosomal dominant polycystic kidney disease was well tolerated in an early-stage trial.

On the losing side, G1 Therapeutics ( GTHX ) shares slumped 43% after the company said its treatment candidate for metastatic triple negative breast cancer failed to achieve statistical significance in a late-stage trial and that it will wind down the program.